March 07, 2024
Maximon, Marcuard Heritage, and GenTwo have announced the launch of a new longevity-related investment opportunity. Their proposal allows professional investors to get access to Maximon's portfolio of longevity companies via an actively managed certificate (AMC). According to Maximon, there have been many requests to launch an AMC focused on longevity. Therefore, Marcuard Heritage, a top...
June 01, 2022
The longevity company builder Maximon has concluded a financing round for AVEA at this year's World Economic Forum. The press release is included here. ZUG, SWITZERLAND — AVEA, the longevity supplement startup with the aim to improve healthspan, announces the closing of a 2.5 million CHF seed financing round led by Maximon, The Longevity Company...
October 07, 2021
The venture capitalist firm Maximon has announced a new longevity-focused fund that focuses on financing early-stage biotechnology companies that increase human healthspan. The firm intends to invest 100 million Swiss francs into such companies. The full press release is presented below. Maximon has launched its 100 million Longevity Co-Investment Fund The Longevity Co-Investment Fund finances...
July 23, 2021
The cryptocurrency world is colliding with aging research and life extension and could change how research gets funded. The cryptocurrency community is getting behind healthy life extension The landscape of research funding and investment is changing, particularly with the influx of interest from the crypto community in the last year or two. A lot of...
March 08, 2021
We kick off the week with some news from Switzerland and introduce the new longevity biotech company builder Maximon. The enthusiasm for technologies to promote longevity and even increase healthy human lifespan seems to be rising in Switzerland. There are frequently articles in the popular press about the topic and we were even asked to...
